BLT 0.00% 2.6¢ benitec biopharma limited

TT results, page-4

  1. 2,524 Posts.
    lightbulb Created with Sketch. 69
    From the ASX release regarding the termination of the TT-034 trial:

    "Final data supporting the primary and secondary endpoints of the study will be reported in CYQ4 2016 when the study is completed."
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.